Double-crosslinked fibrin gel, raw material composition and kit thereof, and application thereof

Patent metadata

Field	Value
Publication number	US-12377188-B2
Application number	US-202318841788-A
Country	US
Kind code	B2
Filing date	Aug 17, 2023
Priority date	Oct 12, 2022
Publication date	Aug 5, 2025
Grant date	Aug 5, 2025

Abstract

The present invention provides a double-crosslinked fibrin gel, which is a solid hydrogel composed of a network structure with a blocking function and a network structure with an adhesion function, where the network structure with the blocking function is a three-dimensional fibrin network, and the network structure with the adhesion function is a three-dimensional photosensitive gel network; each channel of the photosensitive gel network has a group of the fibrin network inside, and each group of the fibrin network has overall continuity; on the whole, the three-dimensional fibrin network disperses disorderly throughout a surface and an interior of the solid hydrogel. The present invention further provides a raw material composition, a kit for preparing the double-crosslinked fibrin gel, and an application of the kit to prepare an in-situ rapid clotting and hemostatic material. The double-crosslinked fibrin gel prepared by the kit has a fast and efficient hemostatic effect, also can be widely applied for hemostasis of accidental trauma or a surgical wound.

First claim

The invention claimed is:

1. A raw material composition for preparing a double-crosslinked fibrin adhesive for rapid hemostasis in a bleeding wound in situ by mixing, comprising: a composition A and a composition B,
wherein in parts by weight,
the composition A comprises 10-200 parts of a photosensitive material, 1-3 parts of a photoinitiator, 0.14-0.28 parts of an enzyme, and 1.11-8.88 parts of a water-soluble inorganic calcium salt, and
the composition B comprises 5-100 parts of the photosensitive material, 1-2 parts of the photoinitiator and 30-50 parts of fibrinogen,
a mass ratio of the composition A to the composition B is 1.4:10-14:1,
the photosensitive material is a methacryloylated polymer or a derivative thereof, a polyacrylate polymer or a derivative thereof, or a composite system comprising the methacryloylated polymer or the polyacrylate polymer,
wherein the methacryloylated polymer or the derivative thereof is at least one polymer selected from the group consisting of methacryloylated gelatin or a derivative thereof, methacryloylated hyaluronic acid or a derivative thereof, methacryloylated sodium alginate or a derivative thereof, methacryloylated silk fibroin or a derivative thereof, methacryloylated chitosan or a derivative thereof, and methacryloylated carboxymethyl chitosan or a derivative thereof,
the enzyme is at least one enzyme selected from the group consisting of human thrombin, recombinant human thrombin, bovine thrombin, porcine thrombin, and hemocoagulase,
wherein the double-crosslinked fibrin adhesive is a solid hydrogel composed of a three-dimensional fibrin network and a three-dimensional photosensitive gel network, each channel of the photosensitive gel network has a group of the fibrin network inside, and each group of the fibrin network has overall continuity, and on the whole, the three-dimensional fibrin network disperses disorderly throughout a surface and an interior of the solid hydrogel.

2. The raw material composition according to claim 1 , wherein parts by weight of the photosensitive material in the composition A are greater than parts by weight of the photosensitive material in the composition B.

3. The raw material composition according to claim 1 , wherein the mass ratio of the composition A to the composition B is 1.4:1-1.4:10.

4. The raw material composition according to claim 1 , wherein, in parts by weight,
the composition A comprises 80-200 parts of the photosensitive material, 1-3 parts of the photoinitiator, 0.14-0.28 parts of the enzyme, and 1.11-8.88 parts of the water-soluble inorganic calcium salt, and
the composition B comprises 30-100 parts of the photosensitive material, 1-2 parts of the photoinitiator, and 30-50 parts of the fibrinogen.

5. The raw material composition according to claim 1 , wherein the polyacrylate polymer or the derivative thereof is selected from the group consisting of polyether diacrylate or a derivative thereof and polyethylene glycol diacrylate or a derivative thereof.

6. The raw material composition according to claim 1 , wherein the composite system comprising the methacryloylated polymer is selected from the group consisting of a methacryloylated gelatin-polyvinyl alcohol system, a methacryloylated gelatin-polyurethane system, a methacryloylated gelatin-polylactic acid system, a methacryloylated gelatin-cellulose system, a methacryloylated hyaluronic acid-polyvinyl alcohol system, a methacryloylated hyaluronic acid-polyurethane system, a methacryloylated hyaluronic acid-polylactic acid system, a methacryloylated hyaluronic acid-cellulose system, a methacryloylated sodium alginate-polyvinyl alcohol system, a methacryloylated sodium alginate-polyurethane system, a methacryloylated sodium alginate-polylactic acid system, a methacryloylated sodium alginate-cellulose system, a methacryloylated silk fibroin-polyvinyl alcohol system, a methacryloylated silk fibroin-polyurethane system, a methacryloylated silk fibroin-polylactic acid system, a methacryloylated silk fibroin-cellulose system, a methacryloylated chitosan-polyvinyl alcohol system, a methacryloylated chitosan-polyurethane system, a methacryloylated chitosan-polylactic acid system, a methacryloylated chitosan-cellulose system, a methacryloylated carboxymethyl chitosan-polyvinyl alcohol system, a methacryloylated carboxymethyl chitosan-polyurethane system, a methacryloylated carboxymethyl chitosan-polylactic acid system, and a methacryloylated carboxymethyl chitosan-cellulose system.

7. The raw material composition according to claim 1 , wherein the photosensitive material is methacryloylated gelatin or a derivative thereof, or methacryloylated silk fibroin or a derivative thereof.

8. The raw material composition according to claim 1 , wherein the photoinitiator is at least one material selected from the group consisting of lithium phenyl (2,4,6-trimethylbenzoyl)phosphinate, 2-hydroxyl-4′-(2-hydroxyethoxy)-2-methylpropiophenone, ethyl (2,4,6-trimethylbenzoyl)phenylphosphinate, 2-methyl-1-[4-methylthiophenyl]-2-morpholino-1-propanone, methyl ortho-benzoylbenzoate, 2-Benzyl-2-(dimethylamino)-4′-morpholinobutyrophenone, and 2,2-azo (2-methyl-N-(2-hydroxylethyl) propionamide).

9. The raw material composition according to claim 1 , wherein the fibrinogen is at least one fibrinogen selected from the group consisting of human fibrinogen, bovine fibrinogen, and porcine fibrinogen.

10. The raw material composition according to claim 1 , wherein the water-soluble inorganic calcium salt is calcium chloride, calcium nitrate, or calcium sulfate.

11. The raw material composition according to claim 1 , wherein the raw material composition is a freeze-dried powder, an injection, a sponge, or a granule.

12. A method of preparing the raw material composition according to claim 1 , comprising:
mixing a photosensitive material and a photoinitiator dissolved in a solvent so as to obtain a mixed solution;
mixing the mixed solution with a solution containing thrombin and a calcium ion so as to obtain a first precursor solution, which has a concentration ratio of the photosensitive material, the photoinitiator, the enzyme, and the calcium ion of 10-200:1-3:0.14-0.28:1.11-8.88,
wherein a storage time of the first precursor solution in a room temperature environment is limited to be less than 30 minutes;
mixing the mixed solution with a solution containing fibrinogen to obtain a second precursor solution, which has a concentration ratio of the photosensitive material, the photoinitiator and the fibrinogen in the second precursor solution of 5-100:1-2:30-50; and
mixing the first precursor solution and the second precursor solution so as to obtain a liquid raw material composition,
wherein the photosensitive material is a methacryloylated polymer or a derivative thereof, a polyacrylate polymer or a derivative thereof, or a composite system comprising the methacryloylated polymer or the polyacrylate polymer; and
the methacryloylated polymer or the derivative thereof is at least one material selected from the group consisting of:
methacryloylated gelatin or a derivative thereof, methacryloylated hyaluronic acid or a derivative thereof, methacryloylated sodium alginate or a derivative thereof, methacryloylated silk fibroin or a derivative thereof, methacryloylated chitosan or a derivative thereof, and methacryloylated carboxymethyl chitosan or a derivative thereof.

13. The method according to claim 12 , further comprising freeze-drying of the liquid raw material composition so as to obtain a solid raw material composition, wherein the solid raw material composition is in a form of a freeze-dried powder, a sponge or a granule.

Assignees

• Univ Zhejiang

Inventors

• Mao Zhengwei
• Yu Lisha
• Wang Weilin
• Ding Yuan

Classifications

• A61L24/08

  Polysaccharides {(A61L24/043 takes precedence)} · CPC title

• A61L24/046

  obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds (A61L24/043 takes precedence) · CPC title

• A61L24/02 Primary

  containing inorganic materials · CPC title

• A61L24/0031

  Hydrogels or hydrocolloids · CPC title

• A61L24/10

  Polypeptides; Proteins {(A61L24/043 takes precedence)} · CPC title